One of our preliminary studies revealed elevated nesfatin-1 levels in patients with T2D and impaired glucose tolerance (IGT), which correlated with insulin resistance (IR) (Zhang et al, 2012). This evidence concerns the gene NUCB2 and type 2 diabetes mellitus.